Campath-1H Induction Plus Rapamycin Monotherapy for Renal Transplantation: Results of a Pilot Study
Top Cited Papers
Open Access
- 1 June 2003
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 3 (6) , 722-730
- https://doi.org/10.1034/j.1600-6143.2003.00120.x
Abstract
Campath‐1H, an anti‐CD52 monoclonal antibody, was used as induction therapy (40 mg i.v. total dose) in 29 primary human renal transplants, and the patients were maintained on rapamycin monotherapy (...Keywords
This publication has 16 references indexed in Scilit:
- Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopeniaArthritis & Rheumatism, 2001
- CAMPATH IH ALLOWS LOW-DOSE CYCLOSPORINE MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1999
- COMBINED HISTOCOMPATIBILITY LEUKOCYTE ANTIGENMATCHED DONOR BONE MARROW AND RENAL TRANSPLANTATION FOR MULTIPLE MYELOMA WITH END STAGE RENAL DISEASE: THE INDUCTION OF ALLOGRAFT TOLERANCE THROUGH MIXED LYMPHOHEMATOPOIETIC CHIMERISMTransplantation, 1999
- Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipientsThe Lancet, 1998
- Inhaled nitric oxide and heparin for infantile primary pulmonary hypertensionThe Lancet, 1998
- PRECLINICAL STUDIES OF ALLOGRAFT TOLERANCE IN RHESUS MONKEYSTransplantation, 1997
- FN18-CRM9 IMMUNOTOXIN PROMOTES TOLERANCE IN PRIMATE RENAL ALLOGRAFTS1Transplantation, 1997
- Renal transplantation in older peopleThe Lancet, 1994
- THE FLOW CYTOMETRIC CROSSMATCHTransplantation, 1989
- Acquired Immune Tolerance to Cadaveric Renal AllograftsNew England Journal of Medicine, 1989